Abstract
The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.
| Original language | English (US) |
|---|---|
| Article number | 1195 |
| Journal | Cancers |
| Volume | 16 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 2024 |
| Externally published | Yes |
Keywords
- androgen receptor
- bladder cancer
- CD44
- glycosylation
- hyaluronic acid
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'CD44 in Bladder Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS